-
MENA region- Pharma Products Exports – Ms. Priyanka Singh Views – Director Taj Pharma Group
Given your expertise in the MEA region, how would you assess the present state of the GCC market and across the wider region? The MENA market faced a slowdown last year, primarily driven by the oil crisis in key countries such as Saudi Arabia, and Algeria, and currency devaluation and economic crises in other countries,…
-
Generics Medicines Initiative Ms. Priyanka Singh Director Taj Pharma
Generics Medicines Initiative: The Beginning: We have seen a lot of vertical integration in health care, typically different health care providers merging, or providers and health plans. But integration of providers into pharmaceutical manufacturing setting aside a little compounding — is pretty unprecedented. Well I would say necessity is the mother of invention, right? This…
-
Compliance and Competitiveness in Indian Pharmaceuticals Industry by Ms. Priyanka Singh Director Taj Pharma Group
Compliance and Competitiveness in Indian Pharmaceuticals Industry: by Ms. Priyanka Singh Director Taj Pharma Group The word “compliance” in India took on a whole new meaning in 2012 when key Indian Pharma Products exports pushed to USA and European Markets without much apprehensions. That new status, known as the “Generalised System” of Preferences plus is…